• NINDS Gives $3.4M to Aquinnah to Advance ALS Therapies Targeting Stress Granules
  • Online Forums Source of Empathy and Support for ALS and Other Patients, Study Says
  • Keeping the Faith
  • AcuraStem Awarded $3.7M to Develop Gene-related Therapy for ALS, Frontotemporal Dementia
  • ALS May Have Negative Affect on Muscles Necessary for Chewing, Study Finds
  • Kentucky Study Looking to Treat Genetic Form of ALS with Clusters in Appalachia
  • Flex Pharma Stops Phase 2 Trial of FLX-787 to Ease Muscle Cramps in ALS Patients
  • Prediction Model May Help Personalize Survival Prognosis in ALS Patients, Researchers Say
  • Higher Risk of Pressure Sores in ALS Patients; Women, Young More Vulnerable, Study Finds
  • Changes in Brain Structure, Blood Flow Linked to Varying Cognitive Deficits in ALS
  • Phase 1/2a Trial Recruiting ALS Patients to Test AstroRx, Potential New Stem Cell Therapy
  • Specific RNA Alterations Key in ALS, Study Suggests